MedTrace Logo

BOL-DP-o-04 in Patients With Low Back Pain and Sciatica

NCT04145310 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2022-12-08

No results posted yet for this study

Summary

The study is aimed to evaluate the pain-relieving effect of BOL-DP-o-04, in addition to SOC, on Low Back Pain and Sciatica.

Conditions

  • Low Back Pain
  • Sciatica

Interventions

DRUG

BOL-DP-o-04 + SCO

sublingual drops

DRUG

Placebo + SCO

sublingual drops

Sponsors & Collaborators

  • Breath of Life International Pharma Ltd

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-27
Primary Completion
2022-07-07
Completion
2022-07-07

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04145310 on ClinicalTrials.gov